PharmaShots Connects Brands & Decision-Makers with Custom Media Solutions PharmaShots Provides Curated News & Insights for the Biopharma & Healthcare Industry PharmaShots is Empowering Decision Makers with Actionable Insights Amplify Your Brand with PharmaShots’ Expert Content Creation & Marketing Solutions PharmaShots Enables Brands to Strategically Connect with Their Target Audiences Deliver Your News to the Right Audience with PharmaShots Newswire CXO TALKS CXO TALKSRethinking Angina Treatment: Jed Litwiniuk and Uwe Tigör on Auxilius Pharma’s AUX001 | PharmaShots CXO Talks CXO TALKSCytek Biosciences on Redefining Flow Cytometry Excellence | PharmaShots CXO Talks CXO TALKSCXO Talks Podcast | Building Smarter Biotech: Venkat Nelabhotla, CEO of Vyome Holdings, on Driving Innovation Across the US–India Corridor CXO TALKSCXO Talks Podcast | The Road to Acquisition: Oncolytics’ CEO Jared Kelly on Clinical Data, IP & Pharma Partnerships EXCLUSIVE INTERVIEW EXCLUSIVEOncolytics Biotech’s Next Chapter: Jared Kelly on Advancing Pelareorep Toward Approval EXCLUSIVEGona Aziz at HLTH Europe 2026 on the Convergence of AI & 5T MRI: United Imaging’s Strategy for Advancing Precision Healthcare EXCLUSIVEExclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight EXCLUSIVEExclusive: Dr. Mónica Domínguez from Smile Train in a Stimulating Conversation with PharmaShots on Why a Healthy Mouth is a Happy Mind EXCLUSIVEExclusive: Kenneth Sake from Blueprint Medicines in an Enlightening Conversation with PharmaShots EXCLUSIVEExclusive Coverage: Dr. Ikshit Sharma from AIMIL Pharmaceuticals in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEAdvancing Care for Hematologic Malignancies: Chris Heery from Arcellx in a Stimulating Dialogue Exchange with PharmaShots EXCLUSIVEDecoding Approval: Moitreyee Chatterjee-Kishore from Astellas in an Exclusive Conversation with PharmaShots LATEST NEWSStay up-to-date Rezolute Reports Enrollment Completion in P-III (upLIFT) Trial of Ersodetug in Tumor Hyperinsulinism 9 hours ago Ocugen and Roots Pharmaceutical Finalize OCU400 Licensing Deal for Retinitis Pigmentosa in MENA Region 10 hours ago Elevar Therapeutics Resubmits US FDA NDA for Camrelizumab + Rivoceranib to Treat 1L uHCC 11 hours ago Alvotech and Advanz Pharma Submit European Regulatory Application for AVT29 (Biosimilar, Eylea 8mg) 13 hours ago Vir Biotechnology and Gilead Enter ~$1.87B Deal to Develop PRO-XTEN Dual-Masked T-Cell Engagers for Solid Tumors 14 hours ago Enodia Therapeutics Inks Over $500M Deal with Pfizer to Develop Sec61-Targeting Small Molecules 15 hours ago Read More Your Daily Dose of Biopharma News & Insights Delivered to Your Inbox. Join the PharmaShots Family of 20000+ subscribers Subscribe Now
Rezolute Reports Enrollment Completion in P-III (upLIFT) Trial of Ersodetug in Tumor Hyperinsulinism 9 hours ago
Ocugen and Roots Pharmaceutical Finalize OCU400 Licensing Deal for Retinitis Pigmentosa in MENA Region 10 hours ago
Elevar Therapeutics Resubmits US FDA NDA for Camrelizumab + Rivoceranib to Treat 1L uHCC 11 hours ago
Alvotech and Advanz Pharma Submit European Regulatory Application for AVT29 (Biosimilar, Eylea 8mg) 13 hours ago
Vir Biotechnology and Gilead Enter ~$1.87B Deal to Develop PRO-XTEN Dual-Masked T-Cell Engagers for Solid Tumors 14 hours ago
Enodia Therapeutics Inks Over $500M Deal with Pfizer to Develop Sec61-Targeting Small Molecules 15 hours ago
